Lantern Pharma Inc.

LTRN · Nasdaq · SIC 2834: Pharmaceutical Preparations
85
SEC Filings

Business Summary

PART I Overview We are an artificial intelligence (A.I.) focused company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development. Our development portfolio includes three clinical stage oncology focused product candidates and consists of small molecules that others have tried, but failed, to develop into an approved commercialized drug, as well as new compounds that we are developing with the assistance of our proprietary ...

Next Earnings

Q2 FY2026 — expected 2026-09-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionLTRNdiscussed_in_filing Artificial Intelligence
topic_mentionLTRNdiscussed_in_filing Cloud Computing
topic_mentionLTRNdiscussed_in_filing Cybersecurity
topic_mentionLTRNdiscussed_in_filing Trusted Computing
topic_mentionLTRNdiscussed_in_filing Blockchain & Crypto
topic_mentionLTRNdiscussed_in_filing Autonomous Vehicles
topic_mentionLTRNdiscussed_in_filing Capital Expenditure
topic_mentionLTRNdiscussed_in_filing Regulation
topic_mentionLTRNdiscussed_in_filing Healthcare & Bio
topic_mentionLTRNdiscussed_in_filing Platform & Ecosystem
topic_mentionLTRNdiscussed_in_filing Sovereign & Government
topic_mentionLTRNdiscussed_in_filing Artificial Intelligence
topic_mentionLTRNdiscussed_in_filing Cloud Computing
topic_mentionLTRNdiscussed_in_filing Cybersecurity
topic_mentionLTRNdiscussed_in_filing Trusted Computing
topic_mentionLTRNdiscussed_in_filing Blockchain & Crypto
topic_mentionLTRNdiscussed_in_filing Autonomous Vehicles
topic_mentionLTRNdiscussed_in_filing Capital Expenditure
topic_mentionLTRNdiscussed_in_filing Regulation
topic_mentionLTRNdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001493152-26-013612EDGAR101K words
2025-03-272024-12-310001641172-25-000926EDGAR—
2024-03-182023-12-310001493152-24-010302EDGAR—
2023-03-202022-12-310001493152-23-008241EDGAR—
2022-03-102021-12-310001213900-22-011581EDGAR—
2021-03-102020-12-310001213900-21-014576EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001493152-25-021927EDGAR20K words
2025-08-132025-06-300001641172-25-023471EDGAR—
2025-05-152025-03-310001641172-25-010547EDGAR—
2024-11-072024-09-300001493152-24-044010EDGAR—
2024-08-082024-06-300001493152-24-030766EDGAR—
2024-05-092024-03-310001493152-24-018422EDGAR—
2023-11-082023-09-300001493152-23-039896EDGAR—
2023-08-092023-06-300001493152-23-027345EDGAR—
2023-05-092023-03-310001493152-23-015940EDGAR—
2022-11-072022-09-300001493152-22-030819EDGAR—
2022-08-082022-06-300001493152-22-021610EDGAR—
2022-05-032022-03-310001213900-22-023583EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001493152-26-013608EDGAR5K words
2026-01-230001493152-26-003314EDGAR—
2025-11-130001493152-25-022134EDGAR—
2025-09-230001493152-25-014652EDGAR—
2025-08-130001641172-25-023489EDGAR—
2025-07-290001641172-25-021407EDGAR—
2025-07-030001641172-25-017810EDGAR—
2025-05-150001641172-25-010541EDGAR—
2025-03-270001641172-25-000917EDGAR—
2025-01-100001493152-25-001685EDGAR—

85 total filings indexed. 57 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001763950
TickerLTRN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedTX

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 04afce5bdf4ece3fd6ada5689099b84c5315a77f9bd0f1a9a63b0a3ee38ca934
parent: 05974c40561fe6764ee4d1d43da2eeedf01791179f5042abd67ce162b99a3f7b
content hash: 94036aebfbf611d57ab12130f2cad97f674b5979f93cf535379dfe413343d179
signed: 2026-04-13T04:46:07.192Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf